Trials / Conditions / Hyperlipoproteinemia

Hyperlipoproteinemia

13 registered clinical trials studyying Hyperlipoproteinemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels NCT07405814	Zentiva, k.s.	N/A
Completed	A Study of LY3561774 in Participants With Mixed Dyslipidemia NCT05256654	Eli Lilly and Company	Phase 2
Unknown	The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia NCT01928342	Zhejiang University	Phase 2 / Phase 3
Terminated	Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia NCT01239992	Ludwig-Maximilians - University of Munich	Phase 4
Completed	Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia NCT01878227	Zhejiang University	Phase 3
Completed	Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia NCT01811082	Zhejiang University	Phase 3
Completed	Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia NCT02933138	Hospices Civils de Lyon	—
Completed	Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe NCT01146522	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia NCT01645046	Zhejiang University	Phase 2
Completed	A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin NCT01057654	University Hospital, Bonn	Phase 3
Completed	Dietary Effects on Lipoproteins and Thrombogenic Activity NCT00000538	University of North Carolina, Chapel Hill	Phase 3
Completed	Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins NCT00001226	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Lipid Research Clinics Population Studies NCT00005128	National Heart, Lung, and Blood Institute (NHLBI)	—